Skip to content

Recovery Housing For Drug Dependent Pregnant Women

Recovery Housing For Drug Dependent Pregnant Women

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00497302
Acronym
HOME
Enrollment
128
Registered
2007-07-06
Start date
2004-11-30
Completion date
2009-08-31
Last updated
2013-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Addiction

Keywords

cocaine, opiate, pregnancy, post-partum, neonatal abstinence syndrome, contingency management, Reinforcement Based Treatment, women

Brief summary

For the past several years our research program has developed and tested an intensive outpatient intervention that is based in social learning theory and employs abstinence contingent access to recovery housing as a routine aspect of an intensive day treatment counseling program. The present project proposes to extend this treatment intervention to the special population of pregnant drug using women enrolled at the Center for Addiction and Pregnancy (CAP). We will compare an enhanced treatment that includes abstinence contingent recovery house living plus intensive individual therapy, to standard care at the CAP program. Specific aims of the project are derived from testing a two-group design are described below: 1. To determine whether financially supported abstinence-contingent recovery house placement plus individual counseling in pregnant drug-dependent women improves prenatal outpatient treatment retention. 2. To determine whether financially supported abstinence-contingent recovery house placement plus individual counseling in pregnant drug-dependent women reduces prenatal drug use. 3. To determine whether financially supported abstinence-contingent recovery house placement plus individual counseling results in better maternal and infant clinical birth outcomes (e.g., birth weight, estimated gestational age (EGA) at delivery, medical complications).

Interventions

BEHAVIORALRBT

Contingency management and behavioral counseling including motivational interviewing

BEHAVIORALusual care

receives usual comprehensive care at Center for Addiction and Pregnancy

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* CAP enrolled * Age 18 or older * Evidence of use of opiate and/or cocaine use in the past 30 days * Assigned to pharmacotherapy free modality * CAP admission at an estimated gestational age (EGA) \<34 weeks

Exclusion criteria

* Endorses current suicidal ideation * Any medical disorders requiring extended or future hospitalization * Meet diagnostic criteria for current DSM-IV alcohol dependence * Meet diagnostic criteria for a current DSM-IV Axis I thought disorder (i.e. schizophrenia) * Demonstrate significant cognitive impairment that precludes them from completing the initial assessment battery

Design outcomes

Primary

MeasureTime frame
Treatment retention, drug free urine samples at follow-up and deliverytreatment entry until 12 months post treatment entry

Secondary

MeasureTime frame
prenatal care compliance, neonatal and birth outcomestreatment entry until 12 months post treatment entry

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026